These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 26636106)
1. Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes. Sardu C; Barbieri M; Rizzo MR; Paolisso P; Paolisso G; Marfella R J Diabetes Res; 2016; 2016():7292564. PubMed ID: 26636106 [TBL] [Abstract][Full Text] [Related]
2. Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes. Sardu C; Barbieri M; Santamaria M; Giordano V; Sacra C; Paolisso P; Spirito A; Marfella R; Paolisso G; Rizzo MR Cardiovasc Diabetol; 2017 Jun; 16(1):75. PubMed ID: 28599667 [TBL] [Abstract][Full Text] [Related]
3. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy. Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186 [TBL] [Abstract][Full Text] [Related]
4. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block. Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V; J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205 [TBL] [Abstract][Full Text] [Related]
5. Functional role of miRNA in cardiac resynchronization therapy. Sardu C; Marfella R; Santulli G; Paolisso G Pharmacogenomics; 2014 Jun; 15(8):1159-68. PubMed ID: 25084208 [TBL] [Abstract][Full Text] [Related]
6. Impact of diabetes mellitus on the clinical response to cardiac resynchronization therapy in elderly people. Sardu C; Marfella R; Santulli G J Cardiovasc Transl Res; 2014 Apr; 7(3):362-8. PubMed ID: 24500410 [TBL] [Abstract][Full Text] [Related]
7. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy. Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Long-Term Survival Benefits With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Versus Without Diabetes Mellitus (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy [MADIT-CRT]). Kutyifa V; Naqvi SY; Brown M; McNitt S; Goldenberg I; Klein H; Moss AJ Am J Cardiol; 2018 Jun; 121(12):1567-1574. PubMed ID: 29625702 [TBL] [Abstract][Full Text] [Related]
9. Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders. Marfella R; Di Filippo C; Potenza N; Sardu C; Rizzo MR; Siniscalchi M; Musacchio E; Barbieri M; Mauro C; Mosca N; Solimene F; Mottola MT; Russo A; Rossi F; Paolisso G; D'Amico M Eur J Heart Fail; 2013 Nov; 15(11):1277-88. PubMed ID: 23736534 [TBL] [Abstract][Full Text] [Related]
10. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study. Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E; J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490 [TBL] [Abstract][Full Text] [Related]
11. The prognostic benefit of cardiac resynchronization therapy is greater in concordant vs. discordant left bundle branch block in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Padeletti L; Aimo A; Vishenvsky B; Schwartz A; McNitt S; Wang PJ; Moss AJ; Emdin M; Zareba W Europace; 2018 May; 20(5):794-800. PubMed ID: 28398490 [TBL] [Abstract][Full Text] [Related]
12. Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT). Martin DT; McNitt S; Nesto RW; Rutter MK; Moss AJ Circ Heart Fail; 2011 May; 4(3):332-8. PubMed ID: 21350054 [TBL] [Abstract][Full Text] [Related]
13. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial. Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831 [TBL] [Abstract][Full Text] [Related]
15. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. Linde C; Abraham WT; Gold MR; St John Sutton M; Ghio S; Daubert C; J Am Coll Cardiol; 2008 Dec; 52(23):1834-1843. PubMed ID: 19038680 [TBL] [Abstract][Full Text] [Related]
16. Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT). Lee AY; Moss AJ; Ruwald MH; Kutyifa V; McNitt S; Polonsky B; Zareba W; Ruwald AC Am J Cardiol; 2015 May; 115(10):1423-7. PubMed ID: 25817576 [TBL] [Abstract][Full Text] [Related]
17. The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). Kutyifa V; Kloppe A; Zareba W; Solomon SD; McNitt S; Polonsky S; Barsheshet A; Merkely B; Lemke B; Nagy VK; Moss AJ; Goldenberg I J Am Coll Cardiol; 2013 Mar; 61(9):936-44. PubMed ID: 23449428 [TBL] [Abstract][Full Text] [Related]
18. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure. Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction). Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC; Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898 [TBL] [Abstract][Full Text] [Related]
20. Baseline functional capacity and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT. Brenyo A; Goldenberg I; Moss AJ; Rao M; McNitt S; Huang DT; Zareba W; Barsheshet A Heart Rhythm; 2012 Sep; 9(9):1454-9. PubMed ID: 22521920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]